Olga Ab
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 19
- HER2/EGFR in Cancer Research 18
- Cancer Treatment and Pharmacology 4
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Jan Pinkas (9 shared papers)Victor S. Goldmacher (6 shared papers)Laura M. Bartle (8 shared papers)Ravi Chari (11 shared papers)Rajeeva Singh (3 shared papers)Robert J. Lutz (3 shared papers)Xiuxia Sun (4 shared papers)Thomas Chittenden (3 shared papers)
- Journals
- Cancer Research (10 papers)ACS Medicinal Chemistry Letters (4 papers)Molecular Cancer Therapeutics (2 papers)Neoplasia (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Olga Ab
23 papers receiving 755 citations
Peers
Comparison fields: 5 of 56
- Oncology 577
- Radiology, Nuclear Medicine and Imaging 398
- Reproductive Medicine 90
- Hematology 99
- Genetics 49
Countries citing papers authored by Olga Ab
This map shows the geographic impact of Olga Ab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Ab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Ab more than expected).
Fields of papers citing papers by Olga Ab
This network shows the impact of papers produced by Olga Ab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Ab. The network helps show where Olga Ab may publish in the future.
Co-authors
The 25 scholars most cited alongside Olga Ab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 194 | |
| 2 | 2015 | 160 | |
| 3 | 2018 | 129 | |
| 4 | 2016 | 90 | |
| 5 | 2019 | 30 | |
| 6 | 2019 | 30 | |
| 7 | 2020 | 29 | |
| 8 | 2004 | 19 | |
| 9 | 2019 | 18 | |
| 10 | Efficacy of IMGN901 (huN901-DM1) in combination with bortezomib and lenalidomide against multiple myeloma cells in preclinical studies | 2008 | 11 |
| 11 | 2019 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2019 | 9 | |
| 14 | 2011 | 7 | |
| 15 | Abstract #2799: Combination therapy with IMGN901 and lenalidomide plus low-dose dexamethasone is highly effective in multiple myeloma xenograft models | 2009 | 6 |
| 16 | 2019 | 5 | |
| 17 | 2010 | 5 | |
| 18 | 2011 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 2024 | 1 |
About Olga Ab
Olga Ab is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Organic Chemistry and Hematology, having authored 23 papers that have together received 776 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Synthesis and pharmacology of benzodiazepine derivatives (5 papers), Cancer therapeutics and mechanisms (5 papers), Cancer Treatment and Pharmacology (4 papers), Multiple Myeloma Research and Treatments (3 papers), Cell Adhesion Molecules Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (577 citations), Radiology, Nuclear Medicine and Imaging (398 citations), Reproductive Medicine (90 citations), Hematology (99 citations) and Genetics (49 citations). Olga Ab has collaborated with scholars based in United States and Germany. Frequent co-authors include Jan Pinkas, Victor S. Goldmacher, Laura M. Bartle, Ravi Chari, Rajeeva Singh, Robert J. Lutz, Xiuxia Sun, Thomas Chittenden, Kathleen R. Whiteman and Yelena Kovtun. Their work appears in journals such as Cancer Research, ACS Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Neoplasia and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.